NeuroproteXeon is Therapeutic Devices in United States that focus on clinical-stage pharmaceutical business. Founded in 2014. They cover business area such as provider, late clinical-stage pharmaceutical and medical device, New York, brain cell death, acute neurologic injury.
2014
( 10 years old in 2024 )
Clinical-stage Pharmaceutical
-
50 Cobham Drive
Orchard Park
New York, NY 14127
United States
Private
providerlate clinical-stage pharmaceutical and medical deviceNew Yorkbrain cell deathacute neurologic injury
* We use standard office opening hours in near NeuroproteXeon's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
NeuroproteXeon is Therapeutic Devices business from United States that founded in 2014 (10 years old in 2024), NeuroproteXeon business is focusing on Clinical-stage Pharmaceutical.
NeuroproteXeon headquarter office and corporate office address is located in 50 Cobham Drive Orchard Park New York, NY 14127 United States.
NeuroproteXeon was founded in United States.
In 2024, NeuroproteXeon is currently focus on clinical-stage pharmaceutical sector.
Above is snippet of Google Trends for "clinical-stage pharmaceutical" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with NeuroproteXeon, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
